Synthesis of enantiopure (S)-6-chlorochroman-4-ol using whole-cell Lactobacillus paracasei biotransformation

MakaleAçık ErişimScopus SJRQ3

Özet

Chromane, which has a fused cyclic structure, is a significant molecule that can be found in the structure of many important compounds. Lactobacillus paracasei BD101 was demonstrated as whole-cell biocatalyst for the synthesis of (S)-6-chlorochroman-4-ol with immense enantioselectivity. The conditions of asymmetric reduction were optimized one factor by one factor using L paracasei BD101 to achieve enantiomerically pure product and complete conversion. Using these obtained optimization conditions, asymmetric reduction of 6-chlorochroman-4-one was performed under environmentally friendly conditions; 6-chlorochroman-4-one, having a fused cyclic structure as previously noted to be difficult to asymmetric reduction with biocatalysts, was enantiomerically reduced to (S)-6-chlorochroman-4-ol with an enantiomeric excess >99% on a high gram scale. This study is the first example in the literature for the enantiopure synthesis of (S)-6-chlorochroman-4-ol using a biocatalyst. Also notably, the optical purity of (S)-6-chlorochroman-4-ol obtained in this study through asymmetric bioreduction using whole-cell biocatalyst is the highest value in the literature. In this study, (S)-6-chlorochroman-4-ol was produced on a gram scale by an easy, inexpensive, and environmentally friendly method, which has shown the production of valuable chiral precursors for drug synthesis and other industrial applications. This study provides a convenient method for the production of (S)-6-chlorochroman-4-ol, which can meet the industrial green production demand of this chiral secondary alcohol.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/bayburt/11959Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/chir.23177Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
23
WoS
23
OpenAlex
24
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorŞahin, Engin
dc.date.accessioned2026-10-29T19:09:00.784109286Z
dc.date.available2026-10-29T19:09:00.784109286Z
dc.date.issued2020
dc.description.abstractChromane, which has a fused cyclic structure, is a significant molecule that can be found in the structure of many important compounds. Lactobacillus paracasei BD101 was demonstrated as whole-cell biocatalyst for the synthesis of (S)-6-chlorochroman-4-ol with immense enantioselectivity. The conditions of asymmetric reduction were optimized one factor by one factor using L paracasei BD101 to achieve enantiomerically pure product and complete conversion. Using these obtained optimization conditions, asymmetric reduction of 6-chlorochroman-4-one was performed under environmentally friendly conditions; 6-chlorochroman-4-one, having a fused cyclic structure as previously noted to be difficult to asymmetric reduction with biocatalysts, was enantiomerically reduced to (S)-6-chlorochroman-4-ol with an enantiomeric excess >99% on a high gram scale. This study is the first example in the literature for the enantiopure synthesis of (S)-6-chlorochroman-4-ol using a biocatalyst. Also notably, the optical purity of (S)-6-chlorochroman-4-ol obtained in this study through asymmetric bioreduction using whole-cell biocatalyst is the highest value in the literature. In this study, (S)-6-chlorochroman-4-ol was produced on a gram scale by an easy, inexpensive, and environmentally friendly method, which has shown the production of valuable chiral precursors for drug synthesis and other industrial applications. This study provides a convenient method for the production of (S)-6-chlorochroman-4-ol, which can meet the industrial green production demand of this chiral secondary alcohol.
dc.identifier.doi10.1002/chir.23177
dc.identifier.eissn1520-636X
dc.identifier.endpage406
dc.identifier.issn0899-0042
dc.identifier.issue3
dc.identifier.pmid31970848
dc.identifier.scopus2-s2.0-85078668774
dc.identifier.startpage400
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/bayburt/11959
dc.identifier.volume32
dc.identifier.wosWOS:000508564000001
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc.
dc.relation.ispartofChirality
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject(S)-6-chlorochroman-4-ol
dc.subjectasymmetric reduction
dc.subjectbiotransformation
dc.subjectchirality
dc.subjectgreen synthesis
dc.subject.classificationChemistry, Medicinal
dc.subject.classificationChemistry, Analytical
dc.subject.classificationChemistry, Organic
dc.subject.classificationPharmacology & Pharmacy
dc.subject.classificationChemistry
dc.subject.otherAlcohol Dehydrogenase
dc.subject.otherBiocatalysis
dc.subject.otherChromans
dc.subject.otherHydrogen-Ion Concentration
dc.subject.otherLactobacillus paracasei
dc.subject.otherStereoisomerism
dc.subject.otherTemperature
dc.subject.otherchroman derivative
dc.subject.otherchemistry
dc.subject.othermetabolism
dc.subject.otherpH
dc.subject.othersynthesis
dc.titleSynthesis of enantiopure (S)-6-chlorochroman-4-ol using whole-cell Lactobacillus paracasei biotransformation
dc.typeArticle
rdl.citation.openalex24
rdl.citation.scopus23
rdl.citation.wos23
rdl.departmentFaculty of Health Sciencies, Department of Nutrition and Dietetics, Bayburt University, Bayburt, Turkey
rdl.oa.statusclosed
rdl.oa.statusgreen
rdl.oa.urlhttps://hdl.handle.net/20.500.12403/2216
rdl.scopus.quartileQ3
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)